Prolonged infusion of ornithine plus dopamine in the treatment of the hepatorenal syndrome: a breakthrough?
Conn
H O
HO
Yale University, New Haven, Connecticut, USA.
D004298:Dopamine / Q000008:administration & dosage / Q000627:therapeutic use*; D006530:Hepatorenal Syndrome / Q000188:drug therapy*; D006801:Humans; D009951:Ornipressin / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D014662:Vasoconstrictor Agents; D009951:Ornipressin; D004298:Dopamine